MDProject’s Post

MedTech Europe has published the results of their latest survey into the status of MDR and IVDR at manufacturers. Key Findings: Shift in Manufacturer Concerns: While finding a Notified Body is less of an issue, uncertainty around costs, timelines, and predictability remains, risking Europe’s attractiveness for innovative devices. Conformity Assessment Efficiency should be improved: Over 50% of conformity assessment time is spent outside the review phase. Streamlining pre-review and certificate issuance could reduce total assessment time. Increased Costs for Manufacturers: Rising costs in clinical evaluations, Post-Market Surveillance (PMS), and certification are challenging manufacturers, with variability across Notified Bodies complicating financial planning. Long-Term Financial Strain: By the end of a five-year certification cycle, IVD manufacturers will spend 70% more on maintenance and re-certification, while MD manufacturers face a 50% increase. https://lnkd.in/eb-fdxqZ

To view or add a comment, sign in

Explore topics